![Cui Ling Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ling Wu
Vorsitzender bei
Guangzhou Fulengen Co., Ltd.
Profil
Derzeit ist Cui Ling Wu Vorsitzende des Aufsichtsrats der Guangzhou Wondfo Biotech Co., Ltd. und Vorsitzende der Guangzhou Fulengen Co., Ltd. Sie ist auch im Vorstand der Da An Gene Co., Ltd. der Sun Yat-sen University und stellvertretende Direktorin am Guangzhou Bio-tech Pharmaceuticals Center und Professorin an der Sun Yat-Sen University. Sie erhielt einen Bachelor-Abschluss von der Guangdong Pharmaceutical University.
Aktive Positionen von Cui Ling Wu
| Unternehmen | Position | Beginn |
|---|---|---|
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 09.03.2010 |
Guangzhou Bio-tech Pharmaceuticals Center | Corporate Officer/Principal | 01.03.2001 |
Guangzhou Fulengen Co., Ltd.
 Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. | Vorsitzender | - |
Ehemalige bekannte Positionen von Cui Ling Wu
| Unternehmen | Position | Ende |
|---|---|---|
| DAAN GENE CO., LTD. | Direktor/Vorstandsmitglied | 27.05.2022 |
| GUANGZHOU WONDFO BIOTECH CO.,LTD | Vorsitzender | - |
Ausbildung von Cui Ling Wu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Daan Gene Co., Ltd.
 Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment | Health Technology |
Guangzhou Bio-tech Pharmaceuticals Center | |
Guangzhou Wondfo Biotech Co., Ltd.
 Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits | Health Technology |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong Pharmaceutical University
 Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangzhou Fulengen Co., Ltd.
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. |
